PRECIGEN, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
PRECIGEN, INC. (PGEN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 167.07 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-01
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 178.31M shares, a 14.86% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 165.53M shares, a 7.07% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 164.07M shares, a 6.71% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-03-31 was 160.34M shares, a 4.83% increase year-over-year.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 167.07M shares, a 8.39% increase from fiscal 2019.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 154.14M shares, a 19.01% increase from fiscal 2018.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 129.52M shares, a 7.94% increase from fiscal 2017.
- PRECIGEN, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 120.00M shares, a 1.71% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | 178.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 171.92M shares derived: average of 2 quarters · filed 2021-03-01 | 169.30M shares derived: average of 3 quarters · filed 2021-03-01 | 167.07M shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 165.53M shares 10-Q · filed 2020-11-09 | 164.80M shares derived: average of 2 quarters · filed 2020-11-09 | 163.32M shares 10-Q · filed 2020-11-09 | 161.29M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | 164.07M shares 10-Q · filed 2020-08-10 | 162.20M shares 10-Q · filed 2020-08-10 | 159.88M shares derived: average of 3 quarters · filed 2021-03-01 | 158.56M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | 160.34M shares 10-Q · filed 2020-05-11 | 157.79M shares derived: average of 2 quarters · filed 2021-03-01 | 156.73M shares derived: average of 3 quarters · filed 2021-03-01 | 155.98M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | 155.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 154.92M shares derived: average of 2 quarters · filed 2021-03-01 | 154.53M shares derived: average of 3 quarters · filed 2021-03-01 | 154.14M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 154.60M shares 10-Q · filed 2020-11-09 | 154.17M shares derived: average of 2 quarters · filed 2020-11-09 | 153.77M shares 10-Q · filed 2020-11-09 | 148.21M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 153.75M shares 10-Q · filed 2020-08-10 | 153.35M shares 10-Q · filed 2020-08-10 | 146.08M shares derived: average of 3 quarters · filed 2021-03-01 | 141.94M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 152.95M shares 10-Q · filed 2020-05-11 | 142.25M shares derived: average of 2 quarters · filed 2021-03-01 | 138.01M shares derived: average of 3 quarters · filed 2021-03-01 | 135.83M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | 131.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 130.54M shares derived: average of 2 quarters · filed 2021-03-01 | 130.12M shares derived: average of 3 quarters · filed 2021-03-01 | 129.52M shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 129.52M shares 10-Q · filed 2019-11-12 | 129.41M shares derived: average of 2 quarters · filed 2019-11-12 | 128.84M shares 10-Q · filed 2019-11-12 | 126.82M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 129.30M shares 10-Q · filed 2019-08-09 | 128.50M shares 10-Q · filed 2019-08-09 | 125.92M shares derived: average of 3 quarters · filed 2020-03-02 | 124.57M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 127.69M shares 10-Q · filed 2019-05-09 | 124.23M shares derived: average of 2 quarters · filed 2020-03-02 | 122.99M shares derived: average of 3 quarters · filed 2020-03-02 | 122.18M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 120.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 120.65M shares derived: average of 2 quarters · filed 2020-03-02 | 120.34M shares derived: average of 3 quarters · filed 2020-03-02 | 120.00M shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 120.52M shares 10-Q · filed 2018-11-08 | 120.12M shares derived: average of 2 quarters · filed 2018-11-08 | 119.74M shares 10-Q · filed 2018-11-08 | 119.45M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | 119.73M shares 10-Q · filed 2018-08-13 | 119.35M shares 10-Q · filed 2018-08-13 | 119.09M shares derived: average of 3 quarters · filed 2019-03-01 | 118.90M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | 118.96M shares 10-Q/A · filed 2018-08-13 | 118.77M shares derived: average of 2 quarters · filed 2019-03-01 | 118.63M shares derived: average of 3 quarters · filed 2019-03-01 | 118.51M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | 118.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 118.46M shares derived: average of 2 quarters · filed 2019-03-01 | 118.36M shares derived: average of 3 quarters · filed 2019-03-01 | 117.98M shares 10-K · filed 2019-03-01 |
| 2016-09-30 | 118.35M shares 10-Q · filed 2017-11-09 | 118.24M shares derived: average of 2 quarters · filed 2017-11-09 | 117.79M shares 10-Q · filed 2017-11-09 | 117.47M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | 118.14M shares 10-Q · filed 2017-08-09 | 117.50M shares 10-Q · filed 2017-08-09 | 117.18M shares derived: average of 3 quarters · filed 2018-03-01 | 115.94M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | 116.86M shares 10-Q · filed 2017-05-10 | 116.70M shares derived: average of 2 quarters · filed 2018-03-01 | 115.21M shares derived: average of 3 quarters · filed 2018-03-01 | 113.74M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | 116.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 114.39M shares derived: average of 2 quarters · filed 2018-03-01 | 112.70M shares derived: average of 3 quarters · filed 2018-03-01 | 111.07M shares 10-K · filed 2018-03-01 |
| 2015-09-30 | 112.24M shares 10-Q · filed 2016-11-09 | 110.78M shares derived: average of 2 quarters · filed 2016-11-09 | 109.24M shares 10-Q · filed 2016-11-09 | |
| 2015-06-30 | 109.32M shares 10-Q · filed 2016-08-09 | 107.72M shares 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | 100.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | 100.22M shares derived: average of 2 quarters · filed 2017-03-01 | 99.78M shares derived: average of 3 quarters · filed 2017-03-01 | 99.17M shares 10-K · filed 2017-03-01 |
| 2014-09-30 | 99.89M shares 10-Q · filed 2015-11-09 | 99.39M shares derived: average of 2 quarters · filed 2015-11-09 | 98.71M shares 10-Q · filed 2015-11-09 | |
| 2014-06-30 | 98.89M shares 10-Q · filed 2015-08-10 | 98.11M shares 10-Q · filed 2015-08-10 | ||
| 2013-12-31 | 40.95M shares 10-K · filed 2016-02-29 | |||
| 2013-06-30 | 5.67M shares 10-Q · filed 2014-08-14 | 5.66M shares 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | 5.53M shares 10-K · filed 2015-03-02 | |||
| 2012-06-30 | 5.48M shares 10-Q/A · filed 2013-10-21 | 5.47M shares 10-Q/A · filed 2013-10-21 | ||
| 2011-12-31 | 5.24M shares 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |